REGENERON PHARMACEUTICALS, INC. Inventory Valuation Reserves
REGENERON PHARMACEUTICALS, INC. (REGN) had Inventory Valuation Reserves of $705.90 million as of 2023-12-31, per its 10-K filed 2024-02-05.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryValuationReserves · last filed 2024-02-05
- 2023-12-31: Inventory Valuation Reserves $705.90M.
- 2023-09-30: Inventory Valuation Reserves $726.20M.
- 2023-06-30: Inventory Valuation Reserves $747.90M.
- 2023-03-31: Inventory Valuation Reserves $752.30M.
| Period end | Inventory Valuation Reserves |
|---|---|
| 2023-12-31 | $705.90M 10-K · filed 2024-02-05 |
| 2023-09-30 | $726.20M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $747.90M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $752.30M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $720.70M 10-K · filed 2024-02-05 |
| 2022-03-31 | $566.50M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $510.00M 10-K · filed 2023-02-06 |
| 2020-12-31 | $136.40M 10-K · filed 2022-02-07 |
| 2013-09-30 | $5.10M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $6.20M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $4.60M 10-Q · filed 2013-05-03 |
| 2012-12-31 | $3.60M 10-Q · filed 2013-11-05 |
| 2011-12-31 | $0.00 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |